Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-034520
Filing Date
2017-05-22
Accepted
2017-05-22 19:44:59
Documents
2
Period of Report
2017-05-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3819
2 POA DOCUMENT poa.txt EX-24.4_725875 3034
  Complete submission text file 0001209191-17-034520.txt   8191
Mailing Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355
Business Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355 6617755300
MANNKIND CORP (Issuer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 150 N. ORANGE GROVE BLVD PASADENA CA 91103
Business Address
KRESA KENT (Reporting) CIK: 0001197571 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50865 | Film No.: 17862418